Leveraging years of technical and business experience in the Life Sciences, LBG’s team of consultants regularly provides business development and transactional support to clients. From traditional sales of products and services, to complex technology licensing and business partnerships, LBG can be your strategic business development partner and support the achievement of your organization’s revenue objectives. LBG’s Business Development offerings include;
- Relationship establishment with targeted companies and key personnel, according to your objectives, which may include both cost effective subcontracting of technical support or broader partnering discussions.
- Technology licensing, including the development of a targeted pitch deck, market assessment and identification of potential licensing partners, engagement of potential partners, and drafting and supporting terms sheets and licensing agreement negotiations.
- Generation of market intelligence or specific competitive intelligence, interpretation of the impact on your organization and strategic recommendations leveraging the conclusions.
- Implementation of recommendations, using LBG expertise and market relationships to provide both strategic and tactical support to grow your organization’s bottom line.
Mergers and Acquisitions
LBG’s team of consultants have broad capabilities and expertise to support your organization’s merger and acquisition (M&A) objectives. We can lead the identification of target companies, facilitate the introduction to and engagement with those companies, and can be your overall trusted partner throughout the entire process. Our network of relationships in the Life Sciences, and our business development experience and connections in the Life Sciences industry afford top-level executive contacts and an ear-to-the-ground approach. Leveraging this expertise, LBG can help you increase share-holder value though divesting existing assets or acquiring new capabilities, offerings and market reach.
LBG has significant due diligence experience in the evaluation Life Sciences companies, and has supported both the acquiring organization and the one being acquired. Our approach is to understand your overall corporate strategy, assess the alignment with the target organization, assess the impact of the acquisition from a market and portfolio management perspective, understand potential financial impact and fully vet the likely timeline of the potential transaction.